Tae han Yook

Prof. Tae han Yook

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JLJun Ho Lee
Jun Ho Lee
HKHongjun Kim
Hongjun Kim
JKJong Uk Kim
Jong Uk Kim
TYTae han Yook
Tae han Yook
KKKyeong-Han Kim
Kyeong-Han Kim
GYGabsik Yang
Gabsik Yang
Alzheimer’s disease (AD) and Parkinson’s disease (PD) are the most common neurodegenerative diseases. Many studies have demonstrated that the release of NLRP3 inflammasome-mediated proinflammatory cytokines by the excessive activation of microglia is associated with the pathogenesis of AD and PD and suggested that the NLRP3 inflammasome plays an important role in AD and PD development. In both diseases, various stimuli, such as Aβ and α-synuclein, accelerate the formation of the NLRP3 inflammasome in microglia and induce pyroptosis through the expression of interleukin (IL)-1β, caspase-1, etc., where neuroinflammation contributes to gradual progression and deterioration. However, despite intensive research, the exact function and regulation of the NLRP3 inflammasome has not yet been clearly identified. Moreover, there have not yet been any experiments of clinical use, although many studies have recently been conducted to improve treatment of inflammatory diseases using various inhibitors for NLRP3 inflammasome pathways. However, recent studies have reported that various natural products show improvement effects in the in vivo models of AD and PD through the regulation of NLRP3 inflammasome assembly. Therefore, the present review provides an overview of natural extraction studies aimed at the prevention or treatment of NLRP3 inflammasome-mediated neurological disorders. It is suggested that the discovery and development of these various natural products could be a potential strategy for NLRP3 inflammasome-mediated AD and PD treatment.

31 December 2019 in Journal of Pharmacopuncture
Verified
Journal Article
Open access
PDF file
SKSeok Hee Kim
Seok Hee Kim
JYJin Won Yang
Jin Won Yang
KKKyung Han Kim
Kyung Han Kim
JKJong Uk Kim
Jong Uk Kim
TYTae han Yook
Tae han Yook
Seok Hee Kim, Jin Won Yang, Kyung Han Kim, Jong Uk Kim, and Tae Han Yook. J Pharmacopuncture 2019;22:225-30. https://doi.org/10.3831/KPI.2019.22.030

31 December 2018 in Journal of Pharmacopuncture
Verified
Journal Article
Open access
PDF file
HRHye-Min Ryu
Hye-Min Ryu
SLSeung-Jeong Lee
Seung-Jeong Lee
EPEun-Jin Park
Eun-Jin Park
SKSu-Gyeong Kim
Su-Gyeong Kim
KKKyeong Han Kim
Kyeong Han Kim
TYTae han Yook
Tae han Yook
Hye-Min Ryu, Seung-Jeong Lee, Eun-Jin Park, Su-Gyeong Kim, Kyeong Han Kim, Yoo Min Choi, Jong Uk Kim, Beom Yong Song, Cheol Hong Kim, Hyun-Min Yoon, and Tae-Han Yook. J Pharmacopuncture 2018;21:258-67. https://doi.org/10.3831/KPI.2018.21.029

27 December 2021 in Toxins
Verified
Journal Article
Open access
PDF file
KKKyeong-Han Kim
Kyeong-Han Kim
HJHyein Jeong
Hyein Jeong
GLGihyun Lee
Gihyun Lee
SJSoobin Jang
Soobin Jang
TYTae han Yook
Tae han Yook
This study was aimed at investigating Korean patients’ experience with bee venom therapy (BVT) and providing evidence to enhance BVT safety. Thus, an anonymous online survey was conducted between August 22 and 28, 2018. Five hundred respondents who underwent pharmacopuncture (PA) within one year were surveyed (sample error: 95 ± 4.38%). Of these, 32 respondents were excluded and 468 were evaluated. Of the 468, 61 reported experiencing adverse events after PA. The adverse event rate was higher in the BV-PA(Bee venom-Pharmacopuncture) group than in the non-A group; however, intergroup differences were insignificant. There were no significant differences in mild symptom intensity between the BV-PA and non-BV-PA groups (p = 0.572). However, there was a significant intergroup difference in severe symptom intensity (p < 0.001). Additionally, the BV-PA and non-BV-PA groups did not significantly differ in their level of satisfaction either overall or in terms of effectiveness and safety (p = 0.414, p = 0.339, and p = 0.675, respectively). Furthermore, the BV-PA and non-BV-PA groups did not differ regarding intent to re-treat (p = 0.722). Severe adverse events such as anaphylactic shock were not reported; however, BVT practitioners should be cautious when applying it.

1 December 2011 in Journal of Acupuncture and Meridian Studies
Verified
Journal Article
Open access
YKYoung-Ju Kim
Young-Ju Kim
MKMin-Chul Kim
Min-Chul Kim
CLChanghyun Lee
Changhyun Lee
JKJong-Uk Kim
Jong-Uk Kim
TYTae han Yook
Tae han Yook
ObjectivesThis study was designed to evaluate the effect of traditional Korean medical therapy, consisting of needle-embedding therapy and pharmacopuncture therapy, on patients with urinary incontinence.MethodsTwenty-nine patients with urinary incontinence underwent two sessions of traditional Korean medical therapy in a month. The pressure and the duration of pelvic muscle contraction were measured and compared. The primary endpoint of the study was improvement in the strength of pelvic floor muscle contraction. The paired t-test was used for the statistical analysis.ResultsBefore treatment, a maximum pressure of 16.03±6.28mmHg and an average pressure of 9.62±4.98mmHg were measured, and the duration was 11.82±12.08 seconds. After the first treatment, the pressures were 27.41±10.46mmHg (maximum) and 18.62±9.72mmHg (average), and the duration was 40.75±60.02 seconds. After the second treatment, the pressures were 29±14.86mmHg (maximum) and 20.31±11.51mmHg (average), and the duration was 34.62±42.02 seconds. Comparisons between before treatment and first treatment results and between before treatment and second treatment results showed statistically significant changes but the difference between the first treatment result and the second treatment result was not statistically significant.ConclusionsPatients receiving traditional Korean medical therapy showed improved pelvic muscle contraction ability after a single treatment. If strength of pelvic floor muscle contraction is improved, symptoms of urinary incontinence also get better. Traditional Korean medical therapy, with a focus on needle-embedding therapy and pharmacopuncture therapy, may be effective for treating urinary incontinence

1 December 2014 in Journal of Pharmacopuncture
Verified
Journal Article
Open access
SKSeok-Hee Kim
Seok-Hee Kim
DJDa-Jung Jung
Da-Jung Jung
YCYoo-Min Choi
Yoo-Min Choi
JKJong-Uk Kim
Jong-Uk Kim
TYTae han Yook
Tae han Yook
The purpose of this study is to analyze trends in domestic studies on pharmacopuncture therapy for treating cervical disease. This study was carried out on original copies and abstracts of theses listed in databases or published until July 2014. The search was made on the Oriental medicine Advanced Searching Integrated System (OASIS) the National Digital Science Library (NDSL), and the Korean traditional knowledge portal. Search words were 'pain on cervical spine', 'cervical pain', 'ruptured cervical disk', 'cervical disc disorder', 'stiffness of the neck', 'cervical disk', 'whiplash injury', 'cervicalgia', 'posterior cervical pain', 'neck disability', 'Herniated Nucleus Pulposus (HNP)', and 'Herniated Intervertebral Disc (HIVD)'. Twenty-five clinical theses related to pharmacopuncture were selected and were analyzed by year according to the type of pharmacopuncture used, the academic journal in which the publication appeared, and the effect of pharmacopuncture therapy. The significant conclusions are as follows: (1) Pharmacopunctures used for cervical pain were Bee venom pharmacopuncture, Carthami-flos pharmacopuncture, Scolopendra pharmacopuncture, Ouhyul pharmacopuncturen, Hwangryun pharmacopuncture, Corpus pharmacopuncture, Soyeom pharmacopuncture, Hwangryunhaedoktang pharmacopuncture, Shinbaro phamacopuncture. (2) Randomized controlled trials showed that pharmacopuncture therapy combined with other methods was more effective. (3) In the past, studies oriented toward Bee venom pharmacopuncture were actively pursued, but the number of studies on various other types of pharmacopuncture gradually began to increase. (4) For treating a patient with cervical pain, the type of pharmacopuncture to be used should be selected based on the cause of the disease and the patient's condition.